Antibiotics found to increasingly fail

Apr 09, 2007

Pediatricians in the United States are increasingly finding that antibiotics are not always ideal for treating ear infections, a report says.

The Denver Post reported on the findings, which are significant to pediatricians -- children are highly susceptible to ear infections.

Antibiotics are typically prescribed right away to patients with ear infections, but doctors have reported on an increase in patients and parents who report that these medications have failed to relieve the infection.

Patricia Yoon, a pediatric ear, nose and throat specialist at The Children's Hospital in Denver told the Post that this is cause for real concern because ear infections account for about one-fourth of all antibiotics prescribed in the United States. Yoon said she thinks an increasing number of strains of resistant bacteria are emerging.

But the problem has also been seen beyond ear infections. The Post reported that the antibiotic erythromycin, which fights off skin infections, was shown to work 71 percent of the time in 1996. By 2001, the drug was reportedly effective only 46 percent of the time.

Copyright 2007 by United Press International

Explore further: Determine patient preferences by means of conjoint analysis

add to favorites email to friend print save as pdf

Related Stories

Audi tests its A7 driverless vehicle on Florida highway

51 minutes ago

German automaker Audi made use of a Florida law passed in 2012 that allows for testing driverless vehicles on Florida highways this past Sunday and Monday, by requesting a shutdown of Tampa's Lee Roy Selmon ...

India's Flipkart raises $1 bn to tackle Amazon

51 minutes ago

India's top e-commerce company Flipkart said Tuesday it had raised $1 billion (60 billion rupees) in funds as it battles US giant Amazon for supremacy in the hyper-competitive local market.

Recommended for you

Determine patient preferences by means of conjoint analysis

3 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments : 0